Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Total Equity

Amag Pharmaceuticals Total Equity Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Total Equity from 2010 to 2020.
  • Amag Pharmaceuticals Total Equity for the quarter ending June 06, 2020 was $249m a -92.77% decrease of -231m year over year
  • Amag Pharmaceuticals Total Equity for the last 12 months ending June 06, 2020 was $249m a -92.77% decrease of -231m year over year
  • Amag Pharmaceuticals Annual Total Equity for 2019 was $280m a -165.02% decrease of -462m from 2018
  • Amag Pharmaceuticals Annual Total Equity for 2018 was $742m a -6.57% decrease of -49m from 2017
  • Amag Pharmaceuticals Annual Total Equity for 2017 was $790m a -18.24% decrease of -144m from 2016
Other Balance Sheet Metrics:
  • Amag Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $1,216m a -52.43% decrease of -637m year over year
  • Amag Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a -3,223.97% decrease of -46m year over year
View Chart On Koyfin

Quarterly AMAG Total Equity Data

06/2020$249m
03/2020$264m
12/2019$280m
09/2019$481m
06/2019$500m
03/2019$615m
12/2018$742m
09/2018$762m
06/2018$727m
03/2018$740m

Annual AMAG Total Equity Data

2019$280m
2018$742m
2017$790m
2016$934m
2015$932m
2014$460m
2013$172m
2012$173m
2011$181m
2010$245m